Humana (NYSE:HUM) Stock Acquired Rep. Lisa C. McClain

Representative Lisa C. McClain (R-Michigan) recently bought shares of Humana Inc. (NYSE:HUM). In a filing disclosed on November 21st, the Representative disclosed that they had bought between $1,001 and $15,000 in Humana stock on October 30th. The trade occurred in the Representative’s “CHARLES SCHWAB 401K > SCHWAB 893” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Humana Trading Up 3.3%

NYSE:HUM opened at $245.73 on Thursday. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35. The firm has a market capitalization of $29.55 billion, a price-to-earnings ratio of 18.86, a PEG ratio of 1.71 and a beta of 0.42. The business’s 50-day moving average price is $263.71 and its two-hundred day moving average price is $256.78.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.95 by $0.29. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. During the same period in the previous year, the company earned $4.16 EPS. The company’s revenue for the quarter was up 11.1% compared to the same quarter last year. On average, equities analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio is currently 33.18%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on HUM. Piper Sandler cut their price objective on Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a report on Thursday, July 31st. Evercore ISI started coverage on shares of Humana in a report on Monday, September 22nd. They set an “in-line” rating and a $295.00 target price on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Humana in a research report on Wednesday, October 8th. Morgan Stanley decreased their price objective on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a research report on Thursday, July 31st. Finally, Barclays lowered their price objective on shares of Humana from $245.00 to $234.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Eight investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $295.94.

Hedge Funds Weigh In On Humana

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Revolve Wealth Partners LLC bought a new stake in shares of Humana in the 4th quarter worth approximately $202,000. Private Advisor Group LLC purchased a new stake in Humana in the first quarter worth $443,000. Kestra Private Wealth Services LLC raised its stake in shares of Humana by 4.1% in the first quarter. Kestra Private Wealth Services LLC now owns 2,648 shares of the insurance provider’s stock valued at $701,000 after buying an additional 105 shares during the period. Teachers Retirement System of The State of Kentucky lifted its position in shares of Humana by 4.0% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 9,293 shares of the insurance provider’s stock valued at $2,459,000 after buying an additional 361 shares during the last quarter. Finally, HighPoint Advisor Group LLC grew its stake in shares of Humana by 15.2% during the 1st quarter. HighPoint Advisor Group LLC now owns 1,739 shares of the insurance provider’s stock worth $451,000 after acquiring an additional 230 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.